<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>Parasite Immunology, 2013, 35, 283&#226;&#8364;&#8220;294                                                                          DOI: 10.1111/pim.12046 <br />  <br />  <br />  <br /> Review Article <br />  <br /> Imaging African trypanosomes <br />  <br /> L. MACLEAN,1 E. MYBURGH,2 J. RODGERS3 &amp; H. P. PRICE1 <br />  <br /> 1 <br />  Centre Immunology Infection, Department Biology/Hull York Medical School, University York, Heslington, York, UK, <br /> 2 <br />  Wellcome Trust Centre Molecular Parasitology, Institute Infection, Immunity Inflammation, College Medical, Veterinary &amp; <br /> Life Sciences, University Glasgow, Glasgow, UK, 3Institute Infection, Immunity Inflammation, College Medical, Veterinary &amp; <br /> Life Sciences, University Glasgow, Glasgow, UK <br />  <br />  <br />  <br />  <br /> SUMMARY <br />                                                                         INTRODUCTION <br /> Trypanosoma brucei extracellular kinetoplastid para- <br /> sites transmitted blood-sucking tsetse fly. They             Human African trypanosomiasis (HAT) caused by <br /> responsible fatal disease human African trypanosomi-            infection African trypanosomes (Trypanosoma <br /> asis (HAT), known sleeping sickness. In late-stage              brucei), transmitted haematophagous <br /> infection, trypanosomes cross blood&#226;&#8364;&#8220;brain barrier                   tsetse fly (Glossina spp.). Two subspecies human infec- <br /> (BBB) invade central nervous (CNS)                       tive: Trypanosoma brucei gambiense, present in <br /> invariably leading coma death untreated. There             West Central Africa, Trypanosoma brucei rhodes- <br /> no available vaccine current late-stage HAT chemother-              iense, East Southern Africa. <br /> apy consists melarsoprol, highly toxic               Human African trypanosomiasis characterized two <br /> causing 8% deaths, nifurtimox&#226;&#8364;&#8220;eflornithine com-             stages, early haemolymphatic stage trypano- <br /> bination therapy (NECT), costly difficult               somes proliferate bite site, travel local lymph <br /> administer. There urgent need identify new           nodes establish infection bloodstream, the <br /> late-stage HAT drug candidates. Here, review                     late meningoencephalitic stage trypanosomes <br /> current imaging tools, ranging fluorescent confocal                cross blood&#226;&#8364;&#8220;brain barrier (BBB) invading central <br /> microscopy live immobilized cells culture whole-               nervous (CNS). This late stage invariably leads <span id='am-6' about='protege:TO' typeof='owl:Thing'>to</span> <br /> animal imaging, providing insight T. brucei biology,           coma death untreated (1, 2). Human African <br /> parasite-host interplay, trypanosome CNS invasion                   trypanosomiasis severe social economic <br /> disease progression. We consider imaging tools             impact sub-Saharan Africa estimated 70 <br /> be used candidate drug screening purposes                million people risk infection. Investment control <br /> lead new chemotherapies.                                             strategies decade led significant <br />                                                                         decline recorded HAT cases &lt;10 000 cases <br /> Keywords animal model, electron microscopy, vivo imag-               reported WHO 2009 time 50 years <br /> ing, <span id='am-85' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-86' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-87' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-88' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-89' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-90' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-91' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-92' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-93' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-94' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-95' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-96' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-97' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-98' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-99' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-100' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-101' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-102' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-103' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-104' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-105' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-106' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-107' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-108' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-109' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-110' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-111' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-112' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-113' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-114' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-115' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-116' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-117' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-118' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-119' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-120' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-121' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-122' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-123' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-124' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-125' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-126' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-127' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-128' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-129' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-130' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-131' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-132' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-133' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-134' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-135' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-136' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-137' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-138' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-139' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-140' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-141' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-142' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-143' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-144' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-145' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-146' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-147' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-148' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-149' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-150' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-151' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-152' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-153' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-154' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-155' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-156' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-157' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-158' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-159' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-160' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-161' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-162' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span>RNA interference</span>, tools techniques, Trypanosoma                (3). This trend continued 2010 2011, and <br /> spp                                                                     attaining WHO roadmap target elimination of <br />                                                                         African trypanosomiasis (&lt;1 case/10 000 population) is <br />                                                                         forecast 2020 (4). However, historically, HAT been <br />                                                                         characterized episodic epidemics resurgences; <br />                                                                         therefore, control efforts surveillance, early diag- <br /> Correspondence: Lorna MacLean, Centre Immunology and <br />                                                                         nosis treatment domestic animals reduce T. brucei <br /> Infection, Department Biology/Hull York Medical School,              reservoirs tsetse fly control maintained to <br /> University York, Heslington, York YO10 5YW, UK                       prevent HAT resurgence. In 2009, 76% of <br /> (e-mail: l.m.maclean@dundee.ac.uk).                                     reported HAT cases Democratic <br /> Current address: Lorna MacLean, Drug Discovery <span id='am-1' about='Thesaurus:Unit' typeof='owl:Thing'>Unit</span>, College            Republic Congo (DRC) (5). In DRC other <br /> of Life Sciences, University Dundee, Dundee DD1 5EH, UK <br /> Disclosures: None. <br />                                                                         regions experiencing war civil unrest, accurate report- <br /> Received: 29 April 2013                                                 ing HAT problematic result signifi- <br /> Accepted publication: 18 June 2013                                  underestimation disease prevalence (6). Research <br />  <br /> &#194;&#169; 2013 The Authors. Parasite Immunology published John Wiley &amp; Sons Ltd                                                         283 <br /> This open access article terms Creative Commons Attribution License, <br /> which permits use, distribution reproduction medium, provided original work properly cited. <br />  L. MacLean et al.                                                                                             Parasite Immunology <br />  <br />  <br /> efforts continued development                programmed interconnected including alterations in <br /> safer, effective chemotherapy tackle disease.           size shape, surface coat, mitochondrion development <br /> Late-stage T. b. rhodesiense HAT currently treated          kinetoplast position (21, 23, 24). Immunofluorescent <br /> highly toxic melarsoprol, causing 8 4% deaths           analyses using cell cycle stage&#226;&#8364;&#8220;specific cytoskeletal <br /> new 10-day regimen (7). Late-stage T. b. gambiense           markers given insights differentiation process <br /> predominantly treated nifurtimox&#226;&#8364;&#8220;eflornithine combi-           procyclic trypomastigote stage tsetse fly <br /> nation therapy (NECT), safer option (8) expensive             midgut salivary gland epimastigote stage. This <br /> and difficult administer (9). In addition, improvement           requires asymmetrical cell division cycle, results <br /> in late-stage diagnostics necessary currently inva-        generation long short daughter cell <br /> sive lumbar puncture required CSF microscopic                complete remodelling subpellicular microtu- <br /> analysis consensus criteria defining             bules prior division. The short epimastigote able to <br /> late-stage infections. HAT clinical features, diagnosis         proliferate attach epithelia reaching salivary <br /> treatment recently reviewed (10).                         glands, long epimastigote appears dead- <br />    In addition clinical relevance, African trypano-        end morphological stage (25, 26). Of particular is <br /> somes powerful model organism research            mechanism T. brucei evades mammalian <br /> eukaryotic cell biology, including mechanisms cell               host immune response switching variable surface <br /> division, intracellular trafficking organelle biogenesis        glycoprotein (VSG) coat process known antigenic <br /> (11&#226;&#8364;&#8220;14). Of particular highly motile flagel-        variation, allowing maintain chronic infection <br /> lum, consists axonemal microtubules (9 + 2 dou-            (27&#226;&#8364;&#8220;30). This clever evasion strategy severely hindered <br /> blet organization) extending basal body covered            development protective vaccine HAT (31). <br /> in membrane (15&#226;&#8364;&#8220;17). The flagellum similar                  The morphological differences parasite stages <br /> structure protein composition primary cilia         demonstrated clearly using electron microscopy <br /> eukaryotes. This review focus imaging                   (EM). Scanning electron micrographs mammalian <br /> technology advanced understanding African                BSF T. b. brucei elongated procyclic form <br /> trypanosomes, model impor-               (PCF), characteristic tsetse fly gut form, shown <br /> tant human pathogen.                                                Figure 1 (32). Electron microscopy used to <br />                                                                     examine morphological <span id='am-7' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-8' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-9' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-10' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-11' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-12' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-13' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-14' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-15' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-16' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-17' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-18' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-19' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-20' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-21' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-22' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-23' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-24' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-25' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-26' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-27' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-28' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-29' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-30' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-31' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-32' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-33' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-34' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-35' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-36' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-37' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-38' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-39' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-40' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-41' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-42' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-43' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-44' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-45' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-46' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-47' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-48' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-49' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-50' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-51' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-52' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-53' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-54' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-57' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-58' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-59' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-60' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-61' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-62' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-63' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-64' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-65' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-66' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-67' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-68' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-69' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-70' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-71' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-72' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-73' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-74' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-75' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-76' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-77' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-78' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-79' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-80' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-81' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-82' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-83' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-84' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span>phenotype</span> following molecular <br />                                                                     manipulations RNA interference (RNAi) gene <br /> IN VITRO AFRICAN TRYPANOSOME IMAGING <br />                                                                     deletion homologous recombination. This illustrated <br /> African trypanosome morphology ultrastructure              transmission electron micrographs T. b. brucei BSF <br /> been extensively studied using classic light microscopy,            cells Lister 427 wild type (33) (Figure 1b left (34)) <br /> transmission electron microscopy (TEM) scanning                 RNAi mutant line following tetracycline-induced <br /> electron microscopy (SEM). These studies revealed              knockdown ARF1 (ADP-ribosylation factor 1) 24 h <br /> that T. brucei curved elongated cells ranging 12           (Figure 1b right, H. Price unpublished data). Expression <br /> to 35 lm <span id='am-5' about='xsp:length' typeof='owl:Thing'>length</span> 1 5 3 5 lm width depending             ARF1 gene essential viability bloodstream <br /> on life cycle stage (18). Trypanosomes kineto-            T. brucei, TEM used demonstrate para- <br /> plastid species characterized disc-shaped kine-          sites depleted ARF1 protein exhibit number mor- <br /> toplast, network mitochondrial circular DNA inside           phological abnormalities prior cell death, including an <br /> single large mitochondrion. Adjacent kinetoplast          enlarged flagellar pocket, multiple nuclei internal fla- <br /> the flagellar pocket, invagination plasma mem-            gella (35). More recently, three-dimensional imaging by <br /> brane major site exo- endocytosis           electron microscope tomography (three-dimensional recon- <br /> to constraints imposed tightly packed subpellicular          structions based serial section electron micrographs) <br /> microtubules (19, 20). A single motile flagellum originates         provided wealth information key processes <br /> at basal body emerges flagellar pocket             organelle structures mechanisms driving <br /> extending anteriorly entire length trypano-          mitosis cytokinesis (reviewed Ref. (36)), struc- <br /> some. Movie S1 shows movement bloodstream form               ture flagellum understanding bihelical <br /> (BSF) T. brucei incubated human blood. Trypano-                motion (37, 38), kinetoplast duplication cycle (39) and <br /> some cell architecture reviewed Ref. (21), T. brucei      cellular architecture flagellar pocket basal <br /> imaging protocols described Ref. (22).                 body (40). <br />    During life cycle, T. brucei alternates environment         Epifluorescence microscopy confocal microscopy <br /> between mammalian host tsetse fly vector. This              routinely used image transgenic parasites <br /> requires developmental changes precisely              expressing fluorescent reporter proteins (live, immobilized <br />  <br /> 284                   &#194;&#169; 2013 The Authors. Parasite Immunology published John Wiley &amp; Sons Ltd, Parasite Immunology, 35, 283&#226;&#8364;&#8220;294 <br />  Volume 35, Number 9/10, September/October 2013                                                                 Imaging African Trypanosomes <br />  <br />  <br /> (a)                                     (b)                                                                       (c) <br />  <br />  <br />  <br />  <br /> (d)                                                                  (f) <br />  <br />  <br />  <br />  <br /> (e)                                                                        (g) <br />  <br />  <br />  <br />  <br /> Figure 1 In vitro African trypanosome imaging. (a) Scanning electron micrographs bloodstream form (BSF) Trypanosoma brucei brucei <br /> strain Lister 427 wild type (top) procyclic form (PCF) T. b. brucei strain EATRO 1125, (bottom). Bar 2 lm. These images were <br /> originally published Ref. (32). (b) Transmission electron micrographs T. b. brucei BSF parasites, wild type (left) (originally published <br /> in Ref. (34)) following tetracycline-induced knockdown ARF1 24 h (right). FL, flagellum; FP, flagellar pocket; N, nucleus; K, <br /> kinetoplast; GA, Golgi apparatus. Bar 1 lm. (c) T. b. brucei BSF parasites probed anti-a-tubulin (green) costained DAPI. <br /> Wild type (top) following tetracycline-inducible RNAi knockdown small GTPase ARL2 (bottom). Bar 5 lm. (d) <br /> Immunofluorescence analysis T. b. brucei BSF determine subcellular localization ARL6. These images dividing cell (one <br /> nucleus kinetoplasts) probed anti-TbARL6 (red) anti-a-tubulin (green) costained DAPI (blue). Bar 5 lm. (e) <br /> Trafficking lipophilic dye FM4-64 T. b. brucei PCF. Cells washed PBS treated 40 lM FM4-64 (Life Technologies <br /> Ltd, Paisley, UK) prior CyGEL immobilization. Samples visualized confocal microscopy, FM4-64 excited 543 nm and <br /> emission collected 560 nm long pass filter. The dye seen plasma membrane flagellar pocket time 0. By <br /> 15 min, signal appeared endosomal system, reaching terminal lysosome 90 min. These images originally published in <br /> Ref. (48). (f) Analysis transgenic T. brucei expressing fluorescent proteins. Flow cytometry analysis visualization confocal <br /> microscopy T. b. brucei GVR35 expressing eGFP costained DAPI (left panel). Ninety-nine percentage cells express high <br /> levels eGFP. Flow cytometry analysis visualization confocal microscopy T. b. rhodesiense IL1852 expressing pHD1034 <br /> tdTomato costained DAPI (right panel). 98% cells express high levels tdTomato. Transformants selected 0 1&#226;&#8364;&#8220;1 lg/mL <br /> puromycin. Bar 5 lm. (g) Imaging T. brucei blood&#226;&#8364;&#8220;brain barrier (BBB) transmigration vitro. Transgenic fluorescent parasites crossing <br /> the BBB in vitro transwell model [monolayer immortalized human brain microvascular endothelial cells (HBMEC)] be <br /> captured real time multiphoton microscopy using collagen gel plug basolateral chamber. <br />  <br />  <br />  <br /> or fixed) cells labelled specific antibodies. These                wild type ARL2 (ADP-ribosylation factor-like 2) <br /> tools highly informative phenotype determination                    RNAi BSF T. brucei labelled DAPI anti-a- <br /> following RNAi gene deletion subcellular local-                  tubulin antibody (H. Price, unpublished data). Immunoflu- <br /> ization studies. Analysis DAPI-stained T. brucei cells                   orescence SEM data revealed knockdown the <br /> can used combination flow cytometry SEM                      small GTPase ARL2 causes defect cytokinesis result- <br /> to determine stage specific proteins play role                ing multinucleated, multiflagellated cells (43). Indirect <br /> the cell cycle (41, 42). Figure 1(c) shows confocal images                  immunofluorescence transmission immunoelectron <br />  <br /> &#194;&#169; 2013 The Authors. Parasite Immunology published John Wiley &amp; Sons Ltd, Parasite Immunology, 35, 283&#226;&#8364;&#8220;294                              285 <br />  L. MacLean et al.                                                                                            Parasite Immunology <br />  <br />  <br /> microscopy techniques employed subcellu-          motility essential viability BSF T. brucei (13). <br /> lar localization small GTPase ARL6 BSF               However, technique does allow reproducible live cell <br /> T. b. brucei (Figure 1d; H. Price, unpublished data) (44).         imaging L. major PCF T. brucei, facilitat- <br /> In humans, ARL6 encoded BBS3, 17 genes                ing real-time capture fundamental eukaryotic cellular <br /> implicated genetic disorder Bardet&#226;&#8364;&#8220;Biedl syndrome.          processes individual cell level. <br /> ARL6 binds directly BBSome protein complex                 We used live cell imaging FRAP analyses in <br /> is required recruitment complex primary cilia       related kinetoplastid Leishmania study export <br /> (45). Unexpectedly, imaging studies T. brucei         pathway hydrophilic acylated surface protein B (HAS- <br /> ARL6 parasite associated flagellum,         PB). Hydrophilic acylated surface protein B only <br /> but instead located electron-dense vesicles through-         expressed infective parasite stages (49, 50) and, together <br /> out parasite cell body (44).                                   small hydrophilic endoplasmic reticulum&#226;&#8364;&#8220;associated <br />                                                                    protein (SHERP), essential metacyclogenesis the <br />                                                                    sand fly vector (51). Hydrophilic acylated surface protein <br /> LIVE CELL IMAGING <br />                                                                    B immunogenic promising vaccine candidate <br /> Live cell imaging invaluable tool real-time analy-       (52, 53). Hydrophilic acylated surface protein B a <br /> sis fundamental processes, including molecular traffick-        nonclassically secreted protein, requiring N-terminal dual <br /> ing. It possible subject live kinetoplastid              acylation trafficking plasma membrane (54). To <br /> parasites advanced microscopy techniques                address mechanism involved, used FRAP to <br /> fluorescence recovery photobleaching (FRAP)              investigate lateral diffusion reporter fusion protein <br /> fluorescence resonance energy transfer (FRET)              HASPB18-GFP detected parasite body, <br /> analysis molecular diffusion protein complexing             plasma membrane, flagellar pocket flagellum. Small <br /> (46). Development live imaging techniques allowed           regions (ROI) plasma membrane <br /> the study highly dynamic processes parasite           photobleached, rate mobility percent- <br /> real time, intraflagellar transport (IFT), flagel-       age recovery used indication speed of <br /> lum-/cilium-specific mechanism conveying molecules          movement percentage mobile vs. immobile mol- <br /> and distal tip organelle defined           ecules. In addition, corresponding fluorescence loss <br /> particles. FRAP spinning disc microscopy                  induced photobleaching (FLIP) additional regions <br /> recently used measure speed IFT particle            outside bleached ROI allowed analysis of <br /> movement flagella T. brucei procyclic cells              HASPB18-GFP movement direction. FRAP small <br /> expressing green fluorescent protein (GFP)-tagged IFT52            ROI cell body plasma membrane showed recovery <br /> (47). This elegant study demonstrated IFT movement            6 4   4 8 s, corresponding FLIPs detected both <br /> is extremely fast trypanosome flagella showed           sides ROI illustrated HASPB18-GFP can <br /> presence independent populations                undergo bidirectional movement inner leaflet of <br /> anterograde IFT trains travelling single flagella,         membrane [Movie S2; (55)]. Interestingly, FRAP over <br /> common fusion events two. Mathematical                 main cell body (leaving external section the <br /> modelling using data predicted 45%          flagellum unbleached) revealed rapid recovery fluores- <br /> IFT protein pool actively used flagellar transport           cence (6 s) short region flagellum fla- <br /> (47), indicating proteins func-          gellar pocket, fluorescence plasma membrane <br /> tions cell.                                                 did recover 37 min following photobleaching. This <br />    One obvious problem live imaging trypano-               suggests presence diffusion barrier <span id='am-163' about='xsp:base' typeof='owl:Thing'>base</span> of <br /> somes cells highly motile flagella,       Leishmania flagellum restricts movement of <br /> most types imaging, need firmly immobilized          flagellar proteins cell body membrane [Movie S3; <br /> without compromising viability. Recently, validated           (55)]. CyGEL immobilization parasites coupled with <br /> new rapid method immobilizing T. brucei Leish-             FRAP analysis valuable tool studying bar- <br /> mania parasites using thermoreversible gel CyGEL                 rier gain better understanding mechanism <br /> (Biostatus Ltd, Shepshed, UK) (48). CyGEL liquid                flagellar trafficking T. brucei Leishmania. <br /> when ice-cold forms solid matrix warming                CyGEL act controlled delivery for <br /> 15&#194;&#176;C above. Leishmania major PCF T. b. brucei              range fluorescent probes PCF T. brucei and <br /> maintained high level cell viability (&gt;95%) following       L. major. These include intercalating agent propidium <br /> 2-h incubation CyGEL. Unfortunately, immobilization             iodide (excitation/emission maxima: 535/617 nm) to <br /> of BSF T. brucei CyGEL caused 90% death 1 h              evaluate cell viability subcellular markers Lysotracker, <br /> (48), supporting studies shown                Mitotracker FM4-64 [N-(3-triethylammoniumpropyl)- <br />  <br /> 286                  &#194;&#169; 2013 The Authors. Parasite Immunology published John Wiley &amp; Sons Ltd, Parasite Immunology, 35, 283&#226;&#8364;&#8220;294 <br />  Volume 35, Number 9/10, September/October 2013                                                       Imaging African Trypanosomes <br />  <br />  <br /> 4-(6-(4-(diethylamino) phenyl) hexatrienyl) pyridinium              (63), generated T. b. brucei GVR35 (strain used in <br /> dibromide] (48). We monitored uptake lipophilic          murine late-stage HAT model (64)) expressing eGFP <br /> styryl dye FM4-64 (excitation/emission maxima: 515/                 (excitation/emission maxima: 488/507 nm) T. b. rhodes- <br /> 640 nm; Life Technologies, Paisley, UK) PCF T. brucei.           iense IL1852 (originally isolated CSF patient <br /> Cells immobilized CyGEL incubated                  Kenya) expressing pHD1034 tdTomato (excitation/ <br /> 40 lM FM4-64 90-min time course. Trypanoso-                  emission maxima: 554/581 nm) (Figure 1f; L. MacLean, <br /> ma brucei imaged using Zeiss LSM510 Meta confo-              unpublished data; plasmid pHD1034, gift <span id='am-3' about='protege:FROM' typeof='owl:Thing'>from</span> <br /> cal microscope. During time, dye moves cell           Z. Mackey, Virginia Tech, USA). Ongoing work involves <br /> body membrane flagellar pocket lysosome              incubation fluorescent parasites blood side <br /> the endosomal (Figure 1e; (48)).                             BBB model transwell (composed monolayer of <br />    Multiphoton microscopy particularly useful live           immortalized human BMEC, gift K. S. Kim, D. <br /> cell imaging longer wavelength low-energy exci-          Grab, Johns Hopkins University, USA), addition col- <br /> tation lasers harmful, allowing cells imaged         lagen gel plug basolateral chamber imaging para- <br /> for longer periods confocal microscopy. Used              site transmigration real time using multiphoton <br /> typically 2-photon mode, approach significant         microscopy (Figure 1g). Generating vitro model sys- <br /> advantage exciting fluorophores focal point          tems important order gain insights poorly <br /> of excitation beam, negating requirement pin-         understood, critical event HAT leading morbidity <br /> hole improving efficiency excitation/emission            mortality. <br /> power (56). These advantages, combined reduced                    In situ imaging transgenic T. brucei lines expressing <br /> light scattering adsorption excitation light          fluorescent proteins valuable tool study- <br /> near infrared spectrum, improve imaging depth com-            ing development parasite tsetse fly vector. <br /> plex (e.g. organoid) cultures (56). Combining                  Studies flies co-infected parasite lines express- <br /> advanced imaging technology generation trans-           ing GFP red fluorescent protein showed a <br /> genic fluorescent T. brucei vitro BBB model (57,          subpopulation yellow hybrids produced sali- <br /> 58) allows tackle challenge mimicking              vary glands vector. This provided evidence <br /> investigating CNS invasion African trypanosomes                  showing site T. brucei genetic exchange <br /> in vitro, critical event HAT disease. Little known        occurs, knowledge direct relevance understand- <br /> about mechanism trypanosome CNS invasion.                    ing population genetics parasite (65, 66). <br /> Access post-mortem human brain tissue limited; <br /> therefore, majority work area per- <br />                                                                     IN VIVO AFRICAN TRYPANOSOME IMAGING <br /> formed mouse models vitro studies. The BBB <br /> is composed endothelial cells line cerebral mi-         Although vitro models invaluable tools, vivo <br /> crovessels surrounded basal lamina astrocytic peri-          studies required provide insight host&#226;&#8364;&#8220;parasite <br /> vascular endfeet. Brain microvascular endothelial cells             interplay reveal details mechanisms involved <br /> (BMEC) form complex tight junctions endothe-              T. brucei CNS invasion subsequent disease progres- <br /> lial cells peripheral tissues, restricting move-     sion. Evidence HAT mouse models reveals the <br /> ment small molecules (59). It thought          host neuroinflammatory response plays role determin- <br /> parasite host factors affect BBB integrity. It         ing trypanosome entry CNS. In T. b. brucei- <br /> proposed studies using vitro BBB model              infected mice, IFN-c shown facilitate T-cell and <br /> brucipain, trypanosome cysteine protease, induces cal-            parasite crossing glia limitans (basement mem- <br /> cium activation signals BMEC protease-activated              brane), parasites captured sets <br /> receptors (PARs), causing brain endothelial bar-            basement membranes IFN-c IFN-c receptor&#226;&#8364;&#8220; <br /> rier dysfunction allows trypanosome BBB transmigra-            deficient mice (67). Furthermore, work HAT path- <br /> tion (58).                                                          ogenesis Uganda high levels systemic <br />    It possible use stably transfected T. brucei (60)     IFN-c patients associated increased disease <br /> tool study T. brucei BBB transmigration real time. We         severity (68). A recent study employed contrast- <br /> used DNA constructs based plasmid vector                     enhanced magnetic resonance imaging (MRI) that <br /> pHD1034 (61, 62) (which integrates parasite gen-           integrity BBB compromised late-stage <br /> ome downstream ribosomal RNA promoter),                   trypanosomiasis mouse model asso- <br /> order produce transgenic lines constitutively expressing         ciated presence severe neuroinflammatory <br /> fluorescent proteins parasite life cycle stages. Using       reaction (69). Until point, effects trypanosome <br /> the efficient AMAXA nucleofection transfection protocol             infection BBB integrity remained equivocal one <br />  <br /> &#194;&#169; 2013 The Authors. Parasite Immunology published John Wiley &amp; Sons Ltd, Parasite Immunology, 35, 283&#226;&#8364;&#8220;294                287 <br />  L. MacLean et al.                                                                                                        Parasite Immunology <br />  <br />  <br /> study, late-stage rat model infection, detecting nei-              assume early-stage drugs gain entry CNS <br /> ther loss tight junction proteins occludin zona                  effectively cure late-stage disease. Unfortunately, this <br /> occludens-1 leakage albumin brain (70). In                 case, treatment early-stage <br /> contrast, second investigation significant                   drugs does reduce parasite burden brain <br /> progressive BBB leakage demonstrated presence                    (J. Rodgers, unpublished data), population parasites <br /> a fluorescent dye brain parenchyma following                        remains following treatment. By combining MRI the <br /> peripheral intravenous injection (71). MRI                     state-of-the-art microscopy techniques detailed this <br /> benefits conventional histological                      review, possible identify areas the <br /> biochemical techniques. For example, MRI allows imaging                    CNS harbour residual population select <br /> of brain identify specific regions                    areas specific ROI MRI analyses. Furthermore, <br /> altered BBB integrity. Furthermore, process con-                 tracking parasite transmigration CNS, may <br /> ducted vivo, precludes occurrence artefacts                 feasible determine BBB leakage associ- <br /> that result following death animal. How-                  ated trypanosome infections direct product of <br /> ever, greatest advantage MRI ability                 trypanosome traversal barrier product the <br /> of technique monitor integrity barrier                ongoing peripheral inflammatory response. <br /> a single animal predefined time course infection                    Thus far, paucity data route of <br /> or treatment. This methodology successfully                       T. brucei primary CNS invasion sequential move- <br /> applied demonstrate rapid restoration BBB func-                  ment maintenance parasites brain dis- <br /> tion following curative course novel oral formula-                  ease progresses. A previous comprehensive morphological <br /> tion trypanocidal drug melarsoprol (72). Because                    study experimental cerebral trypanosomiasis (73) analy- <br /> MRI shown significant reduction BBB integrity                     sed histopathology mouse brain serial sections <br /> following trypanosome infection, logical                    animals infected T. b. brucei LUMP 227 over <br />  <br />  <br />  <br /> Figure 2 Detection Trypanosoma brucei brucei GVR35 eGFP central nervous (CNS). T. b. brucei expressing GVR35 eGFP <br /> were passaged female CD-1 mouse intraperitoneal inoculation 1 9 105 parasites HMI-9 media. On day 10 post-infection, <br /> the trypanosomes harvested 4 9 104 parasites passaged second mouse. After 28 days, mouse exsanguinated by <br /> cardiac puncture brain excised [All vivo experiments authorized United Kingdom Animals (Scientific <br /> Procedures) Act 1986 approved University Glasgow Ethical Review Committee]. (a) Graphical representation of <br /> neuropathology grade days 7&#226;&#8364;&#8220;28 post-infection T. b. brucei GVR35 wild type (grey) eGFP transgenic parasites (green). The <br /> severity neurological reaction T. brucei infection determined neuropathology grading scale 0 4. Briefly, haematoxylin <br /> and eosin&#226;&#8364;&#8220;stained sections hippocampal brain region examined. Normal brain classified grade 0, mild meningitis as <br /> grade 1, moderate meningitis perivascular cuffing grade 2, severe meningitis perivascular cuffing some <br /> inflammatory cells neuropil grade 3 severe meningoencephalitis inflammatory cells parenchyma grade 4. <br /> (Boxes represent mean values, whiskers represent standard error.). (b) Graphical representation parasite load mouse brain over <br /> days 7&#226;&#8364;&#8220;28 post-infection T. b. brucei GVR35 wild type (grey) eGFP transgenic parasites (green). Parasite load determined by <br /> Taqman-PCR detect T. brucei paraflagellar rod (PFR) 2 gene using brains. (c) Confocal microscopic analysis whole-mount <br /> day 28 post-infection brain sections. Following fixation 0 4% paraformaldehyde, brain embedded 8% agarose PBS and <br /> axial sections (200 lm thick) obtained using Leica VT 1000S vibratome. Tissue sections blocked 5% goat serum/0 15% Triton <br /> X-100/PBS 60 min incubated primary antibodies, mouse antismooth muscle actin (Sigma-Aldrich Co Ltd) detect the <br /> vasculature rabbit antineurofilament 200 (Sigma-Aldrich) dilution 1 : 500, 24 h. Sections washed 0 15% Triton <br /> PBS 9 3 left overnight wash buffer 4&#194;&#176;C. Secondary antibodies goat anti-mouse Alexa 594 (pink) goat anti-rabbit Alexa 488 <br /> (green) added dilution 1 : 500 incubated 24 h. Sections washed blocked 5% rabbit serum/0 15% <br /> Triton X-100/PBS 60 min, incubated rabbit anti-green fluorescent protein (GFP) Alexa 647 (red) 1 : 500 dilution (Life <br /> Technologies) 24 h. Sections washed above, fixed 4% PFA 15 min room temperature washed times over <br /> 30 min. Sections gradually dehydrated successive concentrations methanol PBS&#226;&#8364;&#8220;Triton X-100 subsequently incubated in <br /> benzyl alcohol/benzyl benzoate (Sigma-Aldrich Co Ltd) (BABB) MeOH dilution 50% BABB 50% MeOH 10&#226;&#8364;&#8220;15 min at <br /> room temperature glass containers. Finally, sections left 100% BABB 25 min mounted metal slides a <br /> large opening drilled centre coverslip attached using nail varnish. The depression filled fresh <br /> BABB sample transferred slide. Another coverslip placed sealed nail varnish. Sections analysed <br /> using Zeiss LSM710 Meta invert confocal microscope using EC Plan-Neofluar 109/0 3 LD C-Apochromat 409/1 1W objective lens. <br /> The white box left-hand image represents region shown higher magnification images right. T. b. brucei <br /> GVR35 expressing eGFP shown present meninges forebrain (ci) cerebellum (cii) brain <br /> parenchyma (ciii) day 28 pi. This confirmed rabbit anti-GFP Alexa 647 labelling (red). (d) Confocal microscopic analysis whole- <br /> mount day 2 post-infection brain sections. Axial brain sections prepared Figure 2c; however, sections labelled with <br /> rabbit anti-GFAP antibody alone, detected Alexa 594 (pink) visualize astrocytes. T. b. brucei GVR35 expressing eGFP detected in <br /> the cerebellar parenchyma day 2 post-infection. <br />  <br />  <br /> 288                     &#194;&#169; 2013 The Authors. Parasite Immunology published John Wiley &amp; Sons Ltd, Parasite Immunology, 35, 283&#226;&#8364;&#8220;294 <br />  Volume 35, Number 9/10, September/October 2013                                                       Imaging African Trypanosomes <br />  <br />  <br /> 1&#226;&#8364;&#8220;9 weeks using haematoxylin eosin staining. Immu-              et al. proposed route parasite invasion <br /> nofluorescence performed frozen brain                   brain migration vascular com- <br /> sections, parasites labelled antitrypanoso-         partment choroid plexus interstitium, aided the <br /> mal antibodies (against LUMP227 antigens) detected              increased permeability choroid plexus vessels compared <br /> by fluorescein-conjugated secondary antibody. The histo-          cerebral vessels (74), subsequent invasion addi- <br /> pathology revealed parasites cho-       tional brain structures following initiation local <br /> roid plexuses (lateral fourth) weeks 3&#226;&#8364;&#8220;4, mainly          inflammatory reaction choroid plexus. <br /> the interstitium lumen wall vessels,           It possible use transgenic fluorescent T. brucei <br /> small number meninges usually week 6.           combination whole-mount labelling tissue <br /> By immunofluorescence, parasites detected slightly             sections (100&#226;&#8364;&#8220;200 lm) cut using vibrating blade (vibra- <br /> earlier choroid plexuses week 2              tome) confocal microscopy sensitive method for <br /> meninges week 4. In advanced cases, large numbers              detecting T. brucei brain. GVR35 eGFP clones were <br /> of parasites choroid plexuses, perivas-        assessed flow cytometry quantify level of <br /> cular spaces occasionally white matter. Poltera          fluorescence. In best clone, 99% GVR35 eGFP <br />  <br />  <br />  <br />                                                          (b) <br />                        (a) <br />  <br />  <br />  <br />  <br />                        (c) <br />                         (i) <br />  <br />  <br />  <br />  <br />                        (ii) <br />  <br />  <br />  <br />  <br />                        (iii) <br />  <br />  <br />  <br />  <br />                        (d) <br />  <br />  <br />  <br />  <br /> &#194;&#169; 2013 The Authors. Parasite Immunology published John Wiley &amp; Sons Ltd, Parasite Immunology, 35, 283&#226;&#8364;&#8220;294                289 <br />  L. MacLean et al.                                                                                            Parasite Immunology <br />  <br />  <br /> population shown express high level eGFP              24 h infection significant microvascular inflamma- <br /> (Figure 1f), establishing infection 28 days,         tion observed (77). These findings particular <br /> GVR35 eGFP parasites detected wet blood film             recently reported neurological symptoms <br /> using fluorescence microscopy (J. Rodgers, unpublished             patients presenting early-stage T. b. rhodesiense <br /> data). The severity neurological response T. bru-        infections (78). <br /> cei infection determined neuropathology grading              These studies demonstrate fluorescent parasites such <br /> scale 0 4 previously described (75). GVR35              GVR35 eGFP invaluable tool further <br /> wild type eGFP transgenic parasites showed compara-            investigation African trypanosomes mammalian <br /> ble levels neuropathology days 7&#226;&#8364;&#8220;28 post-infection,          host, including live vivo imaging late-stage HAT, and, <br /> both exhibiting increase time displaying mod-          passaged, tsetse fly transmission vector. <br /> erate meningitis perivascular cuffing day 28 <br /> (Figure 2a; J. Rodgers, unpublished data). Therefore, the <br />                                                                    WHOLE-ANIMAL IN VIVO (IVIS) IMAGING <br /> transgenic line valid tool analysing CNS infection. <br /> Parasite load determined brains real-time          The development live whole-animal imaging trans- <br /> quantitative PCR described previously (72) amplifi-          genic mouse models particularly useful visual- <br /> cation paraflagellar rod (PFR) 2 gene,             izing T. brucei dissemination host the <br /> specific kinetoplastids. Similar trends increasing           inoculation site local lymph nodes, establishing blood- <br /> parasite load time following infection             stream infection subsequently CNS infection. Imaging <br /> with wild type eGFP-expressing GVR35 parasite lines            studies allow examine host responses infec- <br /> (Figure 2b; J. Rodgers, unpublished data).                         tion whole-animal level great importance. <br />    Using brain antineurofilament antibody labelling,               Various reporter trypanosome lines expressing biolumines- <br /> detected goat anti-rabbit Alexa 488 (green), pos-        cent proteins generated years <br /> sible obtain overview day 28 post-infection axial         enable noninvasive imaging trypanosome <br /> brain sections using confocal microscopy (Figure 2c left           infections mice. Claes et al. (79) Giroud et al. (80) <br /> panel, white box represents enlarged area right panel;          described generation T. b. brucei 427, T. b. brucei <br /> L. MacLean, unpublished data). Looking higher mag-            AnTat1.1 T. b. gambiense lines expressing Renilla <br /> nification, detected eGFP (excitation also: 488 nm,          luciferase. With use bioluminescence imaging, the <br /> green) confirmed anti-GFP/Alexa 647 (red) <span id='am-4' about='rdfs:label' typeof='owl:Thing'>label</span>-            progression dissemination infection be <br /> ling, apparent eGFP-expressing T. brucei          tracked vivo localization specific organs shown <br /> abundant particularly meninges forebrain             ex vivo imaging. More recently, firefly luciferase <br /> (Figure 2c i) cerebellum (Figure 2c ii)         variant LUC2 (Promega) employed for <br /> cerebellar parenchyma (Figure 2c iii). Preliminary analysis        imaging T. b. brucei infections. <br /> of brains isolated mice day 2 post-infection,                 The monitoring acute infections provides fast method <br /> labelled rabbit anti-GFAP 594 (pink) detect glial          test compounds first-stage trypanosomiasis, but <br /> fibrillary acidic protein, main intermediate filament          new drugs second CNS stage disease <br /> protein expressed astrocytes, revealed GVR35 eGFP               urgently required. The current model trypano- <br /> parasites cerebellar parenchyma (Figure 2d), sug-           CNS infections makes use GVR35 strain of <br /> gesting trypanosome CNS invasion occurs                T. b. brucei, establishes CNS infection 21 days <br /> neurological signs detected. Studies underway           post-infection (64). In original model, mice treated <br /> analyse early invasion determine para-       test compounds 21 days post-infection moni- <br /> site distribution kinetics disease progression using        tored 180 days treatment assessing blood para- <br /> GVR35 eGFP-infected mice. Following labelling, sec-           sitaemia. We modified T. b. brucei GVR35 stably <br /> tions brain imaged using fully automated slide      express firefly luciferase (LUC2), allowing moni- <br /> scanner, allows rapid analysis serial brain sections      toring CNS-stage infections chemotherapy vivo <br /> at time points. Detection parasites brain        imaging (Figure 3). The substrate firefly luciferase, <br /> very quickly following infection supports Frevert et al.s          D-luciferin, readily crosses BBB, making reporter <br /> work using intravital confocal microscopy. In study,          best choice high-sensitivity bioluminescence imaging <br /> green fluorescent cell tracker dye PKH67-labelled T. brucei        brain. Treatment GVR35-LUC2-infected mice with <br /> (excitation/emission maxima: 490/502 nm; Sigma-Aldrich             curative dose melarsoprol (81) abolished biolumines- <br /> Co Ltd, Dorset, UK) monomeric mOrange-expressing               cence. In contrast, mice treated DB75 [2,5-bis(4- <br /> T. brucei (excitation/emission maxima: 548/562 nm; (61,            amidinophenyl)furan], compound shown ineffective <br /> 76)) detected mouse brain parenchyma            CNS trypanosomes (82), bioluminescence was <br />  <br /> 290                  &#194;&#169; 2013 The Authors. Parasite Immunology published John Wiley &amp; Sons Ltd, Parasite Immunology, 35, 283&#226;&#8364;&#8220;294 <br />  Volume 35, Number 9/10, September/October 2013                                                                 Imaging African Trypanosomes <br />  <br />  <br />  <br />  (a) <br />  <br />  <br />  <br />  <br />  (b) <br />  <br />  <br />  <br />  <br /> Figure 3 Bioluminescence imaging assess chemotherapy stage 2 trypanosomiasis. Mice injected intraperitoneally 3 9 104 <br /> Trypanosoma brucei brucei GVR35-LUC2 bloodstream form (BSF) parasites treated 21 days post-infection (a) melarsoprol <br /> (topical application 3 6 mg consecutive days) (b) DB75 (20 mg/kg consecutive days intraperitoneally). Mice were <br /> imaged indicated times infection using IVIS Spectrum (PerkinElmer, Waltham, MA, USA). D-Luciferin (150 mg/kg) injected <br /> intraperitoneally 10 min prior imaging. Bioluminescence shown total flux photons second (p/s) parasitaemia each <br /> mouse shown image ND indicating trypanosomes detected blood samples. The representative mice <br /> are shown entire period. Two colour scales used treatments indicate strong (a) weaker (b) bioluminescent radiance <br /> in photons/s/cm2/steradian. <br />  <br />  <br /> detected heads treated mice increased              biology, rapid progress understand- <br /> spread cervical lymph nodes eventually rest                 ing biology lethal pathogens. Emerging <br /> the body. With new imaging model, bioluminescent                      super-resolution microscopy techniques including stimu- <br /> trypanosomes detected weeks detection                 lated emission depletion (STED), photoactivated light <br /> in blood, providing significant improvement                  microscopy (PALM) stochastic optical reconstruction <br /> post-treatment time required establish promis-               microscopy (STORM) enable detailed structure be <br /> ing compound effective stage 2 (CNS) trypanosomiasis               studied higher resolution using light microscopy (LM), <br /> (E. Myburgh et al., manuscript submitted).                                narrowing gap LM EM. Multipho- <br />                                                                           ton imaging enhanced using latest fluo- <br />                                                                           rescent protein derivatives red-shifted hence <br /> CONCLUSIONS <br />                                                                           imaged greater depths. These excited at <br /> By exploiting recent advances imaging technology,                      longer, deeper penetrating wavelengths emitted light is <br /> coupled developments molecular cellular                       able escape detector greater depths. In <br />  <br /> &#194;&#169; 2013 The Authors. Parasite Immunology published John Wiley &amp; Sons Ltd, Parasite Immunology, 35, 283&#226;&#8364;&#8220;294                              291 <br />  L. MacLean et al.                                                                                                                   Parasite Immunology <br />  <br />  <br /> addition, new technique Clear Lipid-exchanged Acrylam-                        assistance tissue labelling, Zachary Mackey <br /> ide-hybridized Rigid Imaging/Immunostaining/In situ                             (Department Biochemistry, Virginia Polytechnic Insti- <br /> hybridization-compatible Tissue-hYdrogel (CLARITY)                          tute State University, USA) plasmid pHD1034 <br /> recently used imaging molecular phenotyping                        Dennis Grab Kwang Sik Kim (Department of <br /> of intact tissue (83). Employing new imaging tools                        Pathology, Johns Hopkins University School Medicine, <br /> will critical new insight cellular molecular                  Baltimore, USA) HBMEC technical advice the <br /> basis late (CNS)-stage HAT advance future                            BBB model. We thank Deborah Smith, James Brewer <br /> drug development screening programmes.                                      Jeremy Mottram critical reading manu- <br />                                                                                 script. The vitro imaging brain section imaging were <br />                                                                                 funded Wellcome Trust [077503] VIP Wellcome <br /> ACKNOWLEDGEMENTS <br />                                                                                 Trust-funded University York Departmental fellowship <br /> We gratefully acknowledge contributions follow-                        [092430/Z/10/Z]. The vivo (IVIS) imaging work was <br /> ing colleagues: Peter OToole (Technology Facility, Univer-                      funded Bill Melinda Gates Foundation <br /> sity York, UK) technical advice helpful                              [OPPGH5337]. The Wellcome Trust Centre Molecular <br /> discussions, Priyanka Narang (London School Hygiene                          Parasitology supported core funding the <br /> and Tropical Medicine, Immunology Infection, UK)                            Wellcome Trust [085349]. <br />  <br />  <br /> REFERENCES <br /> 1 Blum J, Schmid C &amp; Burri C. Clinical             10 Kennedy PG. Clinical features, diagnosis,               Trypanosoma brucei. Microsc Microanal <br />   aspects 2541 patients second stage          treatment human African trypanoso-               2004; 10: 621&#226;&#8364;&#8220;636. <br />   human African trypanosomiasis. Acta Trop            miasis (sleeping sickness). Lancet Neurol          23   Portman N &amp; Gull K. Proteomics the <br />   2006; 97: 55&#226;&#8364;&#8220;64.                                    2013; 12: 186&#226;&#8364;&#8220;194.                                      Trypanosoma brucei cytoskeleton: advances <br /> 2 Kennedy PGE. Human African trypanoso-            11 Vaughan S &amp; Gull K. The structural mechan-              opportunities. Parasitology 2012; 139: <br />   miasis CNS: current issues chal-         ics cell division Trypanosoma brucei.             1168&#226;&#8364;&#8220;1177. <br />   lenges. J Clin Invest 2004; 113: 496&#226;&#8364;&#8220;504.           Biochem Soc Trans 2008; 36: 421&#226;&#8364;&#8220;424.               24   Matthews KR. Developments differen- <br /> 3 Simarro PP, Cecchi G, Franco JR, et al.          12 Engstler M, Pfohl T, Herminghaus S, et al.              tiation Trypanosoma brucei. Parasitol <br />   Estimating mapping population            Hydrodynamic flow-mediated protein sorting              Today 1999; 15: 76&#226;&#8364;&#8220;80. <br />   risk sleeping sickness. PLoS Negl Trop           cell surface trypanosomes. Cell          25   Rotureau B, Subota I &amp; Bastin P. Molecular <br />   Dis 2012; 6: e1859.                                 2007; 131: 505&#226;&#8364;&#8220;515.                                     bases cytoskeleton plasticity the <br /> 4 WHO. Sustaining Drive Overcome        13 Broadhead R, Dawe HR, Farr H, et al.                    Trypanosoma brucei parasite cycle. Cell <br />   Global Impact Neglected Tropical Diseases.       Flagellar motility required viability        Microbiol 2011; 13: 705&#226;&#8364;&#8220;716. <br />   In Crompton DWT (ed). Second WHO                    bloodstream trypanosome. Nature             26   Sharma R, Peacock L, Gluenz E, Gull K, <br />   Report Neglected Tropical Diseases.              2006; 440: 224&#226;&#8364;&#8220;227.                                     Gibson W &amp; Carrington M. Asymmetric cell <br />   WHO/HTM/NTD/2013.1. 2013. WHO, 2012.             14 He CY, Ho HH, Malsam J, et al. Golgi                    division route reduction cell length <br /> 5 Simarro PP, Cecchi G, Paone M, et al. The           duplication Trypanosoma brucei. J Cell               change cell morphology trypano- <br />   Atlas human African trypanosomiasis:           Biol 2004; 165: 313&#226;&#8364;&#8220;321.                                somes. Protist 2008; 159: 137&#226;&#8364;&#8220;151. <br />   contribution global mapping neglected      15 Tyler KM, Fridberg A, Toriello KM, et al.          27   Vickerman K &amp; Luckins AG. Localisation <br />   tropical diseases. Int J Health Geogr 2010; 9:      Flagellar membrane localization associa-            variable antigens surface coat of <br />   57.                                                 tion lipid rafts. J Cell Sci 2009; 122:            Trypanosoma brucei using ferritin conjugated <br /> 6 Hasker E, Lutumba P, Chappuis F, et al.             859&#226;&#8364;&#8220;866.                                                antibody. Nature 1969; 224: 1125&#226;&#8364;&#8220;1126. <br />   Human African trypanosomiasis             16 Hill KL. Parasites motion: flagellum-           28   Vickerman K. Antigenic variation trypan- <br />   Democratic Republic Congo: loom-           driven cell motility African trypanosomes.           osomes. Nature 1978; 273: 613&#226;&#8364;&#8220;617. <br />   ing emergency? PLoS Negl Trop Dis 2012; 6:          Curr Opin Microbiol 2010; 13: 459&#226;&#8364;&#8220;465.             29   Rudenko G. African trypanosomes: gen- <br />   e1950.                                           17 Vaughan S. Assembly flagellum            ome adaptations immune evasion. <br /> 7 Kuepfer I, Schmid C, Allan M, et al. Safety         role cell morphogenesis Trypanosoma               Essays Biochem 2011; 51: 47&#226;&#8364;&#8220;62. <br />   efficacy 10-day melarsoprol sche-        brucei. Curr Opin Microbiol 2010; 13: 453&#226;&#8364;&#8220;458.     30   Horn D &amp; McCulloch R. Molecular mecha- <br />   dule treatment second stage Rho-      18 Hoare CA. The Trypanosomes Mammals:                  nisms underlying control antigenic <br />   desiense sleeping sickness. PLoS Negl Trop          A Zoological monograph. Oxford, Blackwell               variation African trypanosomes. Curr <br />   Dis 2012; 6: e1695.                                 Scientific Publications, 1972.                          Opin Microbiol 2010; 13: 700&#226;&#8364;&#8220;705. <br /> 8 Alirol E, Schrumpf D, Amici Heradi J,            19 Overath P &amp; Engstler M. Endocytosis, mem-          31   La Greca F &amp; Magez S. Vaccination against <br />   et al. Nifurtimox-eflornithine combination          brane recycling sorting GPI-anchored             trypanosomiasis: the <br />   therapy second-stage gambiense human            proteins: Trypanosoma brucei model                 trypanosome truly ultimate immune <br />   African trypanosomiasis: medecins sans              system. Mol Microbiol 2004; 53: 735&#226;&#8364;&#8220;744.                destroyer escape artist? Hum Vaccin <br />   frontieres experience democratic          20 Field MC &amp; Carrington M. The trypano-                   2011; 7: 1225&#226;&#8364;&#8220;1233. <br />   republic congo. Clin Infect Dis 2013;        flagellar pocket. Nat Rev Microbiol           32   Price HP, Hodgkinson MR, Curwen RS, <br />   56: 195&#226;&#8364;&#8220;203.                                        2009; 7: 775&#226;&#8364;&#8220;786.                                       et al. The orthologue Sjogrens syndrome <br /> 9 Simarro PP, Franco J, Diarra A, Postigo JA       21 Matthews KR. The developmental cell                     nuclear autoantigen 1 (SSNA1) Trypanosoma <br />   &amp; Jannin J. Update field use avail-       biology Trypanosoma brucei. J Cell Sci               brucei immunogenic self-assembling <br />   able drugs chemotherapy human            2005; 118: 283&#226;&#8364;&#8220;290.                                     molecule. PLoS One 2012; 7: e31842. <br />   African trypanosomiasis. Parasitology 2012;      22 Field MC, Allen CL, Dhir V, et al. New             33   Wirtz E, Leal S, Ochatt C &amp; Cross GA. A <br />   139: 842&#226;&#8364;&#8220;846.                                       approaches microscopic imaging                tightly regulated inducible expression system <br />  <br />  <br />  <br /> 292                       &#194;&#169; 2013 The Authors. Parasite Immunology published John Wiley &amp; Sons Ltd, Parasite Immunology, 35, 283&#226;&#8364;&#8220;294 <br />  Volume 35, Number 9/10, September/October 2013                                                                             Imaging African Trypanosomes <br />  <br />  <br />      conditional gene knock-outs domi-          49 Flinn HM, Rangarajan D &amp; Smith DF.                    stream forms Trypanosoma brucei. Mol <br />      nant-negative genetics Trypanosoma bru-            Expression hydrophilic surface protein           Biochem Parasitol 2007; 153: 220&#226;&#8364;&#8220;223. <br />      cei. Mol Biochem Parasitol 1999; 99: 89&#226;&#8364;&#8220;101.          infective stages Leishmania major. Mol     64   Jennings FW &amp; Gray GD. Relapsed para- <br /> 34   Price HP, Goulding D &amp; Smith DF. ARL1                 Biochem Parasitol 1994; 65: 259&#226;&#8364;&#8220;270.                  sitaemia following chemotherapy chronic <br />      essential role Trypanosoma brucei.       50 Depledge DP, MacLean LM, Hodgkinson                   T. brucei infections mice relation <br />      Biochem Soc Trans 2005; 33: 643&#226;&#8364;&#8220;645.                  MR, et al. Leishmania-specific surface anti-          cerebral trypanosomes. Contrib Microbiol <br /> 35   Price HP, Stark M &amp; Smith DF. Trypanoso-              gens sub-genus sequence variation            Immunol 1983; 7: 147&#226;&#8364;&#8220;154. <br />      ma brucei ARF1 plays central role                immune recognition. PLoS Negl Trop Dis           65   Peacock L, Ferris V, Bailey M &amp; Gibson W. <br />      endocytosis golgi-lysosome trafficking.           2010; 4: e829.                                        Intraclonal mating occurs tsetse <br />      Mol Biol Cell 2007; 18: 864&#226;&#8364;&#8220;873.                   51 Sadlova J, Price HP, Smith BA, Votypka J,             transmission Trypanosoma brucei. Parasit <br /> 36   Farr H &amp; Gull K. Cytokinesis trypano-              Volf P &amp; Smith DF. The stage-regulated                Vectors 2009; 2: 43. <br />      somes. Cytoskeleton (Hoboken) 2012; 69:               HASPB SHERP proteins essential           66   Peacock L, Ferris V, Bailey M &amp; Gibson W. <br />      931&#226;&#8364;&#8220;941.                                              differentiation protozoan parasite         Dynamics infection competition <br /> 37   Koyfman AY, Schmid MF, Gheiratmand L,                 Leishmania major sand fly vector, Phle-        strains Trypanosoma brucei <br />      et al. Structure Trypanosoma brucei flagel-        botomus papatasi. Cell Microbiol 2010; 12:            brucei tsetse fly observed using <br />      lum accounts bihelical motion. Proc           1765&#226;&#8364;&#8220;1779.                                            fluorescent markers. Kinetoplastid Biol Dis <br />      Natl Acad Sci USA 2011; 108: 11105&#226;&#8364;&#8220;11108.          52 Stager S, Smith DF &amp; Kaye PM. Immuniza-               2007; 6: 4. <br /> 38   Hoog JL, Bouchet-Marquis C, McIntosh                  tion recombinant stage-regulated sur-     67   Masocha W, Robertson B, Rottenberg ME, <br />      JR, Hoenger A &amp; Gull K. Cryo-electron                 face protein Leishmania donovani                 Mhlanga J, Sorokin L &amp; Kristensson K. <br />      tomography 3-D analysis intact             induces protection visceral leishmani-        Cerebral vessel laminins IFN-gamma <br />      flagellum Trypanosoma brucei. J Struct             asis. J Immunol 2000; 165: 7064&#226;&#8364;&#8220;7071.                 define Trypanosoma brucei brucei penetration <br />      Biol 2012; 178: 189&#226;&#8364;&#8220;198.                           53 Maroof A, Brown N, Smith B, et al. Thera-             blood-brain barrier. J Clin Invest <br /> 39   Gluenz E, Povelones ML, Englund PT &amp;                  peutic vaccination recombinant adeno-            2004; 114: 689&#226;&#8364;&#8220;694. <br />      Gull K. The kinetoplast duplication cycle          virus reduces splenic parasite burden         68   MacLean L, Odiit M, Macleod A, et al. <br />      Trypanosoma brucei orchestrated cyto-           experimental visceral leishmaniasis. J Infect         Spatially genetically distinct African <br />      skeleton-mediated cell morphogenesis. Mol             Dis 2012; 205: 853&#226;&#8364;&#8220;863.                               Trypanosome virulence variants defined by <br />      Cell Biol 2011; 31: 1012&#226;&#8364;&#8220;1021.                     54 Denny PW, Gokool S, Russell DG, Field                 host interferon-c response. J Infect Dis 2007; <br /> 40   Lacomble S, Vaughan S, Gadelha C, et al.              MC &amp; Smith DF. Acylation-dependent pro-               196: 1620&#226;&#8364;&#8220;1628. <br />      Three-dimensional cellular architecture            tein export Leishmania. J Biol Chem           69   Rodgers J, McCabe C, Gettinby G, Bradley <br />      flagellar pocket associated cytoskele-        2000; 275: 11017&#226;&#8364;&#8220;11025.                               B, Condon B &amp; Kennedy PG. Magnetic <br />      ton trypanosomes revealed electron           55 Maclean LM, OToole PJ, Stark M, et al.                resonance imaging assess blood-brain <br />      microscope tomography. J Cell Sci 2009;               Trafficking release Leishmania meta-           barrier damage murine trypanosomiasis. <br />      122: 1081&#226;&#8364;&#8220;1090.                                       cyclic HASPB macrophage invasion. Cell             Am J Trop Med Hyg 2011; 84: 344&#226;&#8364;&#8220;350. <br /> 41   Hammarton TC, Monnerat S &amp; Mottram                    Microbiol 2012; 14: 740&#226;&#8364;&#8220;761.                     70   Mulenga C, Mhlanga JDM, Kristensson K <br />      JC. Cytokinesis trypanosomatids. Curr           56 Squirrell JM, Wokosin DL, White JG &amp;                  &amp; Robertson B. Trypanosoma brucei brucei <br />      Opin Microbiol 2007; 10: 520&#226;&#8364;&#8220;527.                     Bavister BD. Long-term two-photon fluores-            crosses blood-brain barrier tight <br /> 42   Hammarton TC, Clark J, Douglas F,                     cence imaging mammalian embryos with-              junction proteins preserved rat <br />      Boshart M &amp; Mottram JC. Stage-specific                compromising viability. Nat Biotechnol            chronic disease model. Neuropathol Appl <br />      differences cell cycle control Trypanoso-       1999; 17: 763&#226;&#8364;&#8220;767.                                    Neurobiol 2001; 27: 77&#226;&#8364;&#8220;85. <br />      ma brucei revealed RNA interference        57 Grab DJ, Nikolskaia O, Kim YV, et al. Afri-      71   Philip KA, Dascombe MJ, Fraser PA &amp; <br />      mitotic cyclin. J Biol Chem 2003; 278:                trypanosome interactions vi-           Pentreath VW. Blood-brain-barrier damage <br />      22877&#226;&#8364;&#8220;22886.                                          tro model human blood-brain barrier.           experimental African trypanosomiasis. <br /> 43   Price HP, Peltan A, Stark M &amp; Smith DF.               J Parasitol 2004; 90: 970&#226;&#8364;&#8220;979.                        Ann Trop Med Parasitol 1994; 88: 607&#226;&#8364;&#8220;616. <br />      The small GTPase ARL2 required              58 Grab DJ, Garcia-Garcia JC, Nikolskaia OV,        72   Rodgers J, Jones A, Gibaud S, et al. Melar- <br />      cytokinesis Trypanosoma brucei. Mol Bio-           et al. Protease activated receptor signaling          soprol cyclodextrin inclusion complexes as <br />      chem Parasitol 2010; 173: 123&#226;&#8364;&#8220;131.                    required African trypanosome tra-              promising oral candidates treatment <br /> 44  <br /> </body></html>